Artelo Biosciences, Inc. ARTLW
We take great care to ensure that the data presented and summarized in this overview for ARTELO BIOSCIENCES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ARTLW
Top Purchases
Top Sells
About ARTLW
Insider Transactions at ARTLW
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2022
|
Gregory D. Gorgas Pres, CEO, CFO, Treas & Sec |
BUY
Open market or private purchase
|
Indirect |
1,200
+33.33%
|
$4,800
$4.0 P/Share
|
|
Aug 11
2022
|
Gregory D. Gorgas Pres, CEO, CFO, Treas & Sec |
BUY
Open market or private purchase
|
Indirect |
1,200
+50.0%
|
$4,800
$4.03 P/Share
|
|
Apr 16
2021
|
Gregory D. Gorgas Pres, CEO, CFO, Treas & Sec |
BUY
Open market or private purchase
|
Direct |
8,500
+3.04%
|
$8,500
$1.15 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders